Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the reply. That’s why TARONIS is involved in the manufacturing the equipment and negotiating for the separate divisions, separately. ROYALTIES ARE IRRELEVANT FOR PURPOSES HERE. The point is that TARONIS CREATED BOTH COMPANIES AND NEGOTIATED FOR BORH AND MADE DEALS FOR BOTH. The companies may be separate, and the corresponding market caps too. But the people are the same, negotiating for both companies. This is understood and I indicated already.
We wait and see what happens. Taronis obviously spun the TRNF shares off because it owns both entities. Taronis knows the exact market, demand, value and already began to capitalize the market cap with this Turkish deal. The other side to this is that the joint venture has already opened doors to new markets - - Afghanistan, Albania, Armenia, Azerbaijan, Egypt, Georgia, Iraq, Kazakhstan, Moldavia, Pakistan, Turkmenistan, Ukraine and Uzbekistan.
IF TRNF RECEIVES THE $200,000,000.00 deal and executes the supply. The market cap will be based on the assessment of the acetylene replaced value with the MAGNEGAS - - THAT ???? TURKEY BANNED ACETYLENE FOR, AND THAT WAS IN THE PRESS! WE’RE GOLDEN.
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
There is no way in the world that the Turkish Government would set out a hoax and conspire to mislead the press. When we receive the initial $18,750,000.00 then you’ll see whether or not this is true. It wouldn’t make any sense for Taronis and Turkey to jeopardize their integrity. And anyone who thinks this is a scam is out of their minds. The deal was published with the SEC, first and then the press releases followed with the developments. Now we have MC CONSULTING MARKETING TO “Afghanistan, Albania, Armenia, Azerbaijan, Egypt, Georgia, Iraq, Kazakhstan, Moldavia, Pakistan, Turkmenistan, Ukraine and Uzbekistan.”
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
GET READY TO RIDE THE BIG WAVE COMING IN.
The TRNX shares will rise upon payment off the initial $18.75 million from Turkey ????. That initial payment will go towards the $165 million for the first 30 units. The remaining will be the added 70 units at $550,000,000 altogether with the additional $385,000,000 for the total of $550,000,000. I believe the “TRNF” shares will be valued based on the $200,000,000 / year Turkish MAGNEGAS SUPPLY / CONSUMPTION AND APPORTIONED TO TRNF ACCORDINGLY. The water division and the fuel divisions are separate. But the beauty of the company is that the 300KW VENTURI PLASMA ARC UNITS produce the sterilized water and the MAGNEGAS. Either way, the deal is a done deal. Then we have the discounted 50 refurbished units that will be sold through THE TURKISH JV, “MC CONSULTING.” This figure seems like 50 x $5,000,000.00. And that’s the next $250,000,000.00 that comes into play. All of these figures add up to over ONE BILLION USD.
$18,750,000 coming before January 16. Goes towards the TURKEY DEAL. And with all of this money that Taronis has generated this far equals WE ARE ON THE MOONSHOT. THE STOCK GOES UP TO THE MOON FROM HERE AND SHOULD FLY OVER $10.00/SHARE, EASY. Read my previous post. All the agreed figures are in there for your convenience. FASTEN YOUR SEATBELTS AND GET READY!!! THIS IS GOING TO BE BIG.
SALES OVER ONE BILLION DOLLARS: In the last press release Taronis sales price of $5,000,000 for the REFURBISHED 300KW Venturi plasma arc gasification unit is at a $550,000 discount.
The following figures are true and Taronis Technologies completed agreements for ONE BILLION DOLLARS BASED ON THE FOLLOWING FIGURES, INCLUDING THE LATEST NEWS FROM JANUARY 6, 2019, and the deals in TURKEY. The figures are as follows below:
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
FIFTY $5,000,000 300 KW
This is another $250,000,000 added to the $750,000,000 Turkey deal. Paragraph below indicates: “MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million. This means 50 x $5,000,000. The logic here is simple:
Taronis discounted the units because they are “refurbished, like new.” From the initial 30 units at $165,000,000 = $165,000,000/30 = $5,550,000 for each 300KW Venturi plasma arc gasification unit at the new price. Now add another 70 units at $5,500,000 and that = 388,500,000. Now add the$200,000,000/year MagneGas supply to Turkey. And that equals $388,500,000+$200,000,000 = $588,500,000.00+$165,000,000.00 = $753,500,000.00
Now add the fifty refurbished units at $5,000,000 each. And that equals $250,000,000.00 + $753,500,000 = $1,003,500,000.00 TOTAL GROSS SALES AMOUNT. This is ONE BILLION, THREE MILLION, FIVE HUNDRED THOUSAND DOLLARS GROSS. DO THE MATH.
“The initial marketing territory includes Afghanistan, Albania, Armenia, Azerbaijan, Egypt, Georgia, Iraq, Kazakhstan, Moldavia, Pakistan, Turkmenistan, Ukraine and Uzbekistan.
MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million, as well as industry standard royalty payments to be paid periodically, in perpetuity, based on MagneGas production within the territory of each buyer......”
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
BAYER BUYOUT ON THE WAY:
http://codiagnostics.com/co-diagnostics-breakthrough-coprimer-tech-featured-at-pag-xxviii/
“The evaluation of BHQplex™ CoPrimers in flexible PCR-based genotyping will be presented by a representative of Bayer – Crop Science on Monday, January 13....”
https://pharmaboardroom.com/articles/bayer-betting-big-on-cell-gene-therapy/
“Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to bolster its development pipeline and create transformative biotechnological solutions.
German pharmaceutical company Bayer AG is setting its sights on cell and gene therapies, aiming to position itself as a leader in the field.”
ONE BILLION DOLLARS: Taronis is discounting each of the like new refurbished units at $550,000 for each unit. Thus the following figures are true and Taronis Technologies Just completed agreements for ONE BILLION DOLLARS BASED ON THE FOLLOWING FIGURES AMENDED WITH THE LATEST NEWS FROM JANUARY 6, 2019, as follows below:
This is another $250,000,000 added to the $750,000,000 Turkey deal. Paragraph below indicates: MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million. This means 50 x $5,000,000. The logic here is simple: Taronis discounted the units because they are “refurbished, like new.” From the initial 30 units at $165,000,000 = $165,000,000/30 = $5,550,000 for each 300KW Venturi plasma arc gasification unit.
“The initial marketing territory includes Afghanistan, Albania, Armenia, Azerbaijan, Egypt, Georgia, Iraq, Kazakhstan, Moldavia, Pakistan, Turkmenistan, Ukraine and Uzbekistan.
MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million, as well as industry standard royalty payments to be paid periodically, in perpetuity, based on MagneGas production within the territory of each buyer......”
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
We have an $18.75 million dollar payment on arrival before January 16, 2020. This is happening very shortly. And we’re going to rocket higher than yesterday’s $5 million dollar news. However, yesterday’s news is not about $5million dollars. Yesterday’s news is about the exact figures below for anyone who knows basic reading, math and logic:
Taronis is discounting each of the like new refurbished units at $550,000 for each unit. Thus the following figures are true and Taronis Technologies Just completed agreements for ONE BILLION DOLLARS BASED ON THE FOLLOWING FIGURES AMENDED WITH THE LATEST NEWS FROM JANUARY 6, 2019, as follows below:
This is another $250,000,000 added to the $750,000,000 Turkey deal. Paragraph below indicates: MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million. This means 50 x $5,000,000. The logic here is simple: Taronis discounted the units because they are “refurbished, like new.” From the initial 30 units at $165,000,000 = $165,000,000/30 = $5,550,000 for each 300KW Venturi plasma arc gasification unit.
“The initial marketing territory includes Afghanistan, Albania, Armenia, Azerbaijan, Egypt, Georgia, Iraq, Kazakhstan, Moldavia, Pakistan, Turkmenistan, Ukraine and Uzbekistan.
MC Consulting shall initially market fifty 300KW Venturi plasma arc gasification units at a sales price of $5 million, as well as industry standard royalty payments to be paid periodically, in perpetuity, based on MagneGas production within the territory of each buyer......”
https://finance.yahoo.com/news/taronis-fuels-executes-letter-intent-140010100.html
https://smartwatermagazine.com/news/taronis-technologies/taronis-completes-sterilization-cyanobacteria-hibiscus-lake-florida?amp
“This was a positive milestone for our emerging water technology applications, commented Scott Mahoney, CEO of Taronis. We gathered a great deal of critical data related to the efficacy of our solution, as well as the economic viability of a commercially scalable version of our current mobile water decontamination plasma arc demonstration unit.
With this successful pilot, we plan to now shift our focus to seek out a potential commercial partner with whom we would look to introduce this solution at a larger scale.
We have identified several promising potential partners with a strong strategic fit with our vision for a combined solution. Our goal is to identify a joint venture or licensing arrangement as soon as practically possible for our cyanobacteria solution,” concluded Scott Mahoney.”
TARONIS’ WORLD CHANGING PATENT: https://patentimages.storage.googleapis.com/4a/8b/69/9123fe4483fdca/US20150151269A1.pdf
Taronis Technologies EXCLUSIVE MAGNEGAS DEAL WITH TURKEY ???? is just the tip of the iceberg.
MOON SHOT—FINALLY
https://www.globenewswire.com/news-release/2019/12/12/1960006/0/en/Taronis-Fuels-Completes-Turkey-JV-Incorporation.html
“This official government signing event is the culmination of almost two years of hard work. To have the opportunity to partner at the very highest level of industry with strong and clear government support is a major accomplishment and a powerful endorsement for our technology and our team.”
“We look forward to the signing event next week, and are eager to get started on the mass production of our 300 KW Venturi plasma arc gasification units for immediate deployment to Ankara in early 2020,” concluded Mr. Mahoney.
https://www.taronistech.com/news-media/press-releases/detail/2756/taronis-and-ta-group-provide-turkey-business-update
“In fact, I believe there should be no other gas used to cut metal in my country but MagneGas.”
“Second, our relationship with Taronis and Infinite Fuels is extremely strong, and we are supporting both companies to the very highest levels of authority here in Turkey. We are very fortunate to be on excellent terms with some of the most important and influential leaders in the history of Turkey, and they are also strong supporters of what we are trying to accomplish with Taronis,” continued Mr. Ay.
$26.00/Share. Here’s the new numbers. Turkey is paying $165,000,00 for 30 units.
100 300 KW Venturi Plasma Arc Gasification Units amounts to a Cost of $550,000,000. Which is $385,000,000 in addition to the $165,000,000.
$550,000,000+$200,000,000=$750,000,000 or $.75billion.
In terms of market cap and share price, this equates to 28.68 times than the current market cap. And this
equates to 28.68(.91)=$26.00/share. $26.00/share.
https://www.globenewswire.com/news-release/2019/12/30/1965025/0/en/Republic-of-Turkey-to-Ban-Acetylene-Other-Metal-Cutting-Fuels.html
HOLY SHIT! They (TARONIS TECHNOLOGY) really did it! THE TURKEY DEAL IS AMAZING! This project all started with a desire to produce an alternative automotive fuel. THE TWO VIDEO LINKS BELOW LED TO THE SALE OF MAGNEGAS PRODUCTION IN ALL OF ISTANBUL TURKEY. AND NOW THIS LED TO THE BAN ON ACETYLENE BY A TURKISH GOVERNMENT MANDATE. AND THE WHOLE DEAL IS WORTH $.75billion ($750,000,0000). HOLY SHIT! THIS IS AMAZING.
SEPTEMBER 14, 2006
I need more information about the new developments of SRMX and to know when this stock will go to $5.00. Please advise.
https://budgeting.thenest.com/happens-value-issued-stock-common-stock-redeemed-canceled-32057.html
Good Read: What Happens to the Value of the Issued Stock When Common Stock Is Redeemed & Canceled?
“The trend in earnings-per-share is a vital factor in stock valuation, so buyback in theory should make the stock more valuable. This is the primary reason that companies redeem their shares -- to benefit shareholders, including officers and directors who have an investment in the company, as well as employees holding stock options.“
Check the link to understand what’s happening. Legacy may redeem the shares.
https://budgeting.thenest.com/happens-value-issued-stock-common-stock-redeemed-canceled-32057.html
The Wall Street Journal has a “$2.00 price target” on Legacy Reserves Stock with a “HOLD” rating. Legacy reserves is not finished. This company will be bought out or merge. The company is still in business. We’re sitting on a winner. Be patient with this. Legacy is a great company with a lot of bank financing. Check the link.
https://www.wsj.com/market-data/quotes/LGCYQ/research-ratings
TBLT is compliant. There is no deficiency for TBLT on the NASDAQ Noncompliant company list. Check below:
https://listingcenter.nasdaq.com/noncompliantcompanylist.aspx
Revenue of $5.02M (+27.7% Y/Y) means R/S not necessary. Increasing product line, additional retail, specialty and industrial product market reach favors future price, revenue and profit increase. S/P holding support for additional gain and upward momentum.
There will not be a reverse split any time soon.
Any reverse stock split will not be implemented before the date indicated after the shareholder meeting "on or before, December 31, 2021. Read below from link: And please post a screenshot of it on StockTwits.
https://seekingalpha.com/filing/4469997:
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
The 2019 annual meeting of shareholders (the “Annual Meeting”) of ToughBuilt Industries, Inc. (the “Company”) will be held at the Company’s corporate offices at 25371 Commercentre Drive, Suite 200, Lake Forest, CA 92630, on June 7, 2019, beginning at 4:00 PM local time. At the Annual Meeting, the holders of the Company’s outstanding common stock will act on the following matters:
1. To elect five directors for a one-year term expiring in 2020.
2. To grant the Board of Directors the authority to increase its shares of authorized common stock from 100,000,000 to 200,000,000.
3.To grant the Board of Directors discretionary authority to effect a reverse split of the Company’s issued and outstanding stock in a ratio of 1:2-1:10 on or before December 31, 2021.
4. To approve the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 20% below the market price of our common stock, as required by and in accordance with Nasdaq Marketplace Rule 5635(d).
5. To approve any change of control that could result from the potential issuance of securities in the non-public offerings following approval of Proposal No. 3, as required by and in accordance with Nasdaq Marketplace Rule 5635(b).
6.To approve amendments to the Company’s 2018 Equity Incentive Plan to (i) increase the number of authorized shares thereunder to 20,000,000 and (ii) to eliminate the performance-based compensation exception to the deductibility limitations under Section 162(m) of the Internal Revenue Code and to include any individual who was our then current or former named executive officers as a “covered employee,” such that payments to former employees will be subject to the deduction limitations thereunder.
7. The ratification of the appointment of Marcum , LLP, as the Company’s independent registered certified public accountant for the fiscal year ended December 31, 2019.
8. To transact such other business as may be properly brought before the 2019 Annual Meeting and any adjournments thereof.
Shareholders of record at the close of business on April 30, 2019 are entitled to notice of and to vote at the 2019 Annual Meeting and any postponements or adjournments thereof.
It is hoped you will be able to attend the 2019 Annual Meeting, but in any event, please vote according to the instructions on the enclosed proxy as promptly as possible. If you are able to be present at the 2019 Annual Meeting, you may revoke your proxy and vote in person.
Dated: May 2, 2019 By Order of the Board of Directors:
/s/ Michael Panosian
Michael Panosian,
Chairman of the Board of Directors
It seems like this guy Egan is a real douche, who can't sell his products for CoDiagnostics, along with the Douche Brent Satterfield that has my money held up in their fraudulent scam stock. If their products, that I believed in were so fucking good then they would be selling and the company would be known to be very proficient in molecular diagnostics and PCR genetic amplification. But from the decline in their stock price, seems that they're doing nothing but wasting time and money. If they wind up in a legal action I wouldn't be surprised. Seems like it's a scam. I hope I'm wrong. But If I'm right I'll be on the class action list of represented plaintiff's. They better make sure they're not fucking around.
I really believed that Codiagnostics was an intelligent company that would act responsibly to maintain a good impression for it's investors and the sciences. But from what I can see on their website they fail to maintain the integrity of their website. The "Stock Info" page and "Financial Info / Filings" pages are down because their security certificates are expired. I contacted them, wrote to Egan and sent them emails yesterday and they still haven't corrected this. I mean, I'm invested and it was accidental that I bought the stock. But now I'm beginning to question whether or not they care about their integrity, especially after I notified them and they represent accurate diagnostic testing equipment. Check out the links, below:
http://codiagnostics.com/investors/stock-info/
http://codiagnostics.com/investors/financial-info-filings/
It looks Like we're FUCKED with Codiagnistics, taking our money and using to cover for India's expenses that they can't raise with their products and patents. Though I positioned in this stock by accident, and thought that it is a good company. I’m beginning to have doubts.
It may very well be that CoDiagnostics may be subject to criminal or class action suits for breaches of investor trust and possible embezzlement. Who knows, maybe the company knows how to manipulate the stock market with mathematical certainty and we’re the suckers.
I'm not positioned. Don't worry.
Don't sell. Bring it up.
The company is scared of becoming successful with the SVM-RFE because of the great demand to infringe on it. On top of this Health Discovery Corp is also profiting from the lawsuits and infringements that they won in the past. So the company can be relying on (additional) lawsuit damages, because in reality, they haven't done anything worthy of news coverage and still remain in the pink. I sold my shares this morning GTC, even. No regrets, but I also did a lot of research on this matter. I learned lot of things here -- so I gained and I have never lost in the stock market. But something doesn't make sense about this company and their market cap should be in the billions after all of the patent applications and/or infringements on the patents and almost two decades. Good luck to all. I'll be watching this from time to time. But in my opinion this company is up to something very shady -- as there is no logical explanation why Intel could post the SVM-RFE on their website and Health Discovery doesn't have anything on thei website. Who knows, maybe Intel's in on the scandal too. https://software.intel.com/en-us/articles/improving-svm-performance-with-intel-daal
It just doesn't make any sense at all.
Today's news is consistent with then mentioned plans to sell in Q3 19.
https://www.businesswire.com/news/home/20190311005185/en/
Will market third quarter 2019,between July-September.
http://spotlightgrowth.com/index.php/2019/03/05/saddle-ranch-media-inc-otc-pink-srmx-skyrockets-200-after-providing-update-on-t-mobile-us-inc-nasdaq-tmus-collaboration/
We are scheduled to submit our final NB IoT PCle platform for certification and our proprietary multi- layer B2B Cloud System to T-Mobile in April 2019, and we continue to refine our NB IoT Air Quality Monitor with the plan to launch this into the consumer market by third quarter, 2019.
SkyFidelity/Verizon Mini Cell Tower
https://www.wirelessdesignonline.com/doc/skyfidelity-introduces-mini-cell-tower-technology-0001
Verizon launches industry's first LTE Category M1 (Cat M1) nationwide network for IoT
https://www.prnewswire.com/news-releases/verizon-launches-industrys-first-lte-category-m1-cat-m1-nationwide-network-for-iot-300431812.html
SkyFidelity Introduces Mini Cell Tower Technology
https://www.wirelessdesignonline.com/doc/skyfidelity-introduces-mini-cell-tower-technology-0001
Tri Cascade Hooks up with u-blox
https://www.aglmediagroup.com/tri-cascade-hooks-up-with-u-blox/
It will climb. May not be this week or months, but it will once the smoke clears. The other factor is the next Press release.
https://www.businesswire.com/news/home/20120917005584/en/Health-Discovery-Corporation-Issues-Update-Challenges-Intel
The following paragraph comes from the above link:
"A fundamental principle of patent law is that the addition of one or more elements to a patented claim does not avoid infringement. In this case, Intel merely added a standard computer operation to the Company’s SVM-RFE method. Furthermore, possession of a patent on a series of steps does not avoid infringement of a patent covering a subset of those steps."
Health Discovery crushed Intel on all arguments that Intel alleged. Intel openly attempted to mislead the patent office by altering the SVM-RFE by adding on to it. I made reference to this last week. And it cannot be done, since Intel was/also attempting to build the kernel data -- on top of the SVM-RFE, underneath. It can't be done, because the kernel data was layered on the SVM-RFE ,owned by Health Discovery. Intel's in deep shit, because they actually tried to do this and then patent it. Then Intel Lost, was cancelled and Health Discovery prevailed on all litigated matters.
It's all a matter of time for the price. Health Discovery has very strong options to litigate. and the Stock price may rise, assuming that Health discovery is not manipulating the price -- which would be a very stupid thing to do, considering the technology they have under protected patent.
T-Mobile and AT&T are both very knowledgeable in preparing for the 5G launch and working with other companies getting ready for 2020. Saddle Ranch Media, along with Subsidiaries "TriCascade/Sky Fidelity" are entering the wireless arena, developing products for 4G and 5G infrastructure. T-mobile and AT&T provide strong promotional support for Sky Fidelity and TriCascade. Sky Fidelity is working with AT&T, Tricascade is working with T-Mobile. So Saddle Ranch Media is working with T-Mobile and AT&T through subsidiaries to diversify products into the growing Wireless infrastructure. Looks good, so far.
https://www.otcmarkets.com/stock/SRMX/news/SkyFidelity-Enters-Into-Product-Development-Agreement-with-AT-amp-T-for-IoT-Smart-Home-Eco-System?id=180660&b=y
Look at:
http://spotlightgrowth.com/index.php/2019/03/05/saddle-ranch-media-inc-otc-pink-srmx-skyrockets-200-after-providing-update-on-t-mobile-us-inc-nasdaq-tmus-collaboration/
Look at pages 16, 22 and 24 in the link below:
http://www.otcmarkets.com/financialReportViewer?symbol=SRMX&id=208634
-Page 16, says:
"Current IoT Cloud platformsinclude the TRI BRIGHTconnect™(IoT Cloud System), togetherwith innovative IoT devicessuch as Smart Outlets, a Voice-Overlight switch/dimmer, IP Cameraand Voiceadvanced IoT Temperature Systemand a Smart Self-Internet Ultimate IoT Gateway Thermostat-THERMORING(partneredwith T-Mobile NB IoT for USA). Ourtechnology empowers consumers to monitor and change their energy usage and household behavior to become much moreenergy efficient."
-Page 22 says, in the link, below:
"Tri Cascade is strategically working and partnering with Google Smart Home and IoT networking with T-Mobile USA."
-Page 24 says:
"Tri Cascade is using uBlox NB IoTSARA-R410M Moduledeveloping smart city platform and devices under T-Mobile NB IoT network.Tri Cascade Google Smart Neighborhood development will be integrated into the Tri Cascade Smart City project with T-Mobile for USAbusiness strategy development and other countries’ telecom NB IoT as well as the part of global business direction."
https://backend.otcmarkets.com/otcapi/company/dns/news/document/35252/content
https://www.24-7pressrelease.com/press-release/459539/tri-cascade-inc-announces-new-partnerships-at-ces-2019
Patents Assigned to Health Discovery Corporation
https://patents.justia.com/assignee/health-discovery-corporation
https://patents.justia.com/patent/8095483
Support vector machine—recursive feature elimination (SVM-RFE)
Identification of a determinative subset of features from within a group of features is performed by training a support vector machine using training samples with class labels to determine a value of each feature, where features are removed based on their the value. One or more features having the smallest values are removed and an updated kernel matrix is generated using the remaining features. The process is repeated until a predetermined number of features remain which are capable of accurately separating the data into different classes.
Description
RELATED APPLICATIONS
This application is a continuation of application Ser. No. 12/890,705, filed Sep. 26, 2010, which is a continuation of application Ser. No. 11/928,784, filed Oct. 30, 2007, now U.S. Pat. No. 7,805,388, which is a continuation of application Ser. No. 10/494,876, filed as application No. PCT/US02/35576 on Nov. 7, 2002, now U.S. Pat. No. 7,475,048, which claims the priority of U.S. provisional application Ser. No. 60/347,562, filed on Nov. 7, 2001, and is a continuation-in-part of application No. PCT/US02/16012, filed May 20, 2002, now U.S. Pat. No. 7,318,051, which claims priority to each of U.S. provisional application Nos. 60/292,133, filed May 18, 2001, No. 60/292,221, filed May 23, 2001, and No. 60/332,021, filed Nov. 21, 2001, and is a continuation-in-part of application Ser. No. 10/057,849, filed Jan. 24, 2002, now U.S. Pat. No. 7,117,188, which is a continuation-in-part of application Ser. No. 09/633,410, filed Aug. 7, 2000, now U.S. Pat. No. 6,882,990, which claims the benefit of provisional application Nos. 60/161,806, filed Oct. 27, 1999, No. 60/168,703, filed Dec. 2, 1999, No. 60/184,596, filed Feb. 24, 2000; and No. 60/191,219, filed Mar. 22, 2000. Each of the above-identified applications is incorporated herein by reference.
Support vector machine-based method for analysis of spectral data
https://patents.justia.com/patent/8463718
Description
RELATED APPLICATIONS
This application is a continuation of U.S. application Ser. No. 11/929,169, filed Oct. 30, 2007, which is a continuation of U.S. application Ser. No. 10/267,977, filed Oct. 9, 2002, now issued as U.S. Pat. No. 7,617,163, which claims priority of U.S. provisional application Ser. No. 60/328,309, filed Oct. 9, 2001 and is a continuation-in-part of application Ser. No. 10/477,078, filed Nov. 7, 2003, now issued as U.S. Pat. No. 7,353,215, which was the U.S. national stage filing of International application No. PCT/US02/14311 filed in the U.S. Receiving Office on May 7, 2002 which claims priority to each of the following U.S. provisional patent applications: Ser. No. 60/289,163, filed May 7, 2001, and Ser. No. 60/329,874, filed Oct. 17, 2001, and is also a continuation-in-part of U.S. patent application Ser. No. 10/057,849, filed Jan. 24, 2002, now U.S. Pat. No. 7,117,188, which is a continuation-in-part of application Ser. No. 09/633,410, filed Aug. 7, 2000, now U.S. Pat. No. 6,882,990.